Kshitij Anand of ET has identified five companies recommended by brokerages with the potential...
IndiaNivesh
IndiaNivesh has issued an update report stating that the 'Sell' rating for Ajanta Pharma...
IndiaNivesh has conducted a comprehensive review of companies in various sectors and identified the...
Auto ancillary & component stocks have become the red-hot favourite amongst savvy investors. All...
IndiaNivesh has provided an update on the status of the stocks in their coverage...
IndiaNivesh has provided an update on the status of five Pharma stocks in their...
Dharmesh Kant of IndiaNivesh has announced Camson Bio Technologies, a small cap, as his...
Ajanta Pharma has been a great wealth-creator stock. It reported robust Q2FY15 results. However,...
Ajay Relan of CX Advisors deserves to be complimented for his brilliant stock picking....
Daljeet Kohli of IndiaNivesh has issued an update report on Mastek in the wake...
